NVO is expected to report earnings to rise+5.02% to 75 cents per share on May 02

A.I.dvisor
at Tickeron.com
05/01/24
Loading...
NVO - Novo-Nordisk A/S
Novo-Nordisk A/S Earnings Graph
Q1'24
Est.
$0.75
Q4'23
Beat
by $0.05
Q3'23
Beat
by $4.32
Q2'23
Missed
by $0.64
Q1'23
Beat
by $0.06
The last earnings report on December 31 showed earnings per share of 72 cents, beating the estimate of 67 cents. P/B Ratio (37.453) is normal, around the industry mean (10.139). P/E Ratio (48.009) is within average values for comparable stocks, (115.202). NVO's Projected Growth (PEG Ratio) (2.476) is slightly higher than the industry average of (1.468). Dividend Yield (0.011) settles around the average of (0.015) among similar stocks. P/S Ratio (17.301) is also within normal values, averaging (226.762). With 7.84M shares outstanding, the current market capitalization sits at 566.59B.
View a ticker or compare two or three
NVODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com